ESPN DeportesChina no acepta disculpas de Mbappé y seguirá sin emitir LaLigaESPNNBA Power Rankings: First-week stats and trends that stand out for all 30 teamsPunchVIDEO: Police, man clash over NAFDAC number on zobo drinksBollywood HungamaSudhir Mishra SLAMS IndiGo after luggage containing his medicines is left behind in Delhi: “Extremely disappointing and frustrating”ESPN CricinfoShadman's unbeaten 99 gives Bangladesh first-day honours against WIDaily MaverickTHEATRE REVIEW: First Date — A comedic musical flashback to the days before dating appsZDF heuteEntdecken Sie das ZDF-NachrichtenstudioCBS NewsQatari mediators hand Iran new proposal to end the warBBC BusinessYour pay, energy bills and savings: How the Budget affects youCollider‘Black Mirror’ Meets ‘The Office’ in Your Next Hulu Weekend BingeVanguardReps panel approves ₦100.5bn Yobe airport reimbursementConsequenceThe Neighbourhood Announce 2027 Tour Dates
The Daily Newsstand · Free, Always
Wednesday, October 28, 2026

Indonesia weighs tighter ketamine controls amid surge in seizures, abuse cases

Translate

Analysts urge authorities to first conduct comprehensive studies before reclassifying ketamine as a drug

3-MIN READ3-MIN

Rising ketamine abuse and a series of major drug seizures in Indonesia have fuelled calls for tighter controls on the substance, but a proposed reclassification has raised concerns that tougher penalties could further strain the country’s overcrowded prisons.

Last week, Indonesian police and customs officials intercepted the Mongolian-flagged vessel MT Global 168 in the Malacca Strait, seizing 1.16 tonnes of ketamine hydrochloride packed in 58 sacks. National police chief Suyudi Ario Seto said the vessel was owned by a company based in Malaysia’s Johor Bahru.

The illegal cargo was worth 3.48 trillion rupiah (US$192 million), Suyudi said, adding that the crew of seven Indonesians and one Chinese national had been detained.

View the original on South China Morning Post →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.